Assessment of the relationship of basal serum anti-mullerian hormone levels with oocyte quality and pregnancy outcomes in patients undergoing ICSI

Iranian Journal of Reproductive Medicine

Volumn 13, Issue 4, 2015, Pages 231-236

  Aydın, Gültekin Adanaş ^a   Yavuz, Arzu ^b   Terzi, Hasan ^b   Kutlu, Tayfun ^c  

^a Bursa Cekirge State Hospital   (Turkey)

^b Kocaeli Derince Education and Research Hospital   (Turkey)

^c Zeynep Kamil Women's and Children's Hospital   (Turkey)

Author keywords

Anti Mullerian hormone; Oocyte quality; Ovary reserve

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LEUPRORELIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; TRIPTORELIN; RECOMBINANT HCG; RECOMBINANT HORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EMBRYO QUALITY; EMBRYO TRANSFER; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; MENSTRUAL CYCLE; OOCYTE COUNT; OOCYTE MATURATION; OOCYTE QUALITY; OVARIAN RESERVE; OVARY FOLLICLE COUNT; OVULATION INDUCTION; PREDICTIVE VALUE; PREGNANCY OUTCOME; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TURKEY (REPUBLIC); OOCYTE; OVARY FOLLICLE CELL; PREDICTION;

EID: 84930423924     PISSN: 16806433     EISSN: 20082177     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Verlinsky Y, Cieslak J, Ivakhnenko V. Prevention of age-related aneuploidies by polar body testing of oocytes. J Assist Reprod Genet 1999; 16: 165-169.
2. Teixeria J, Mahesweran S, Donahoe PK. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr Rev 2001; 22: 657-674.
3. Durlinger AL, Gruijters MJ, Kramer P, Karels B, IngrahamHA, Nachtigal MW, et al. Anti-Mullerian hormone inhibit sinitiation of primordial follicle growth in the Mouse ovary. Endocrinology 2002; 143: 1076-1084.
4. Arabzadeh S, Hossein G, Rashidi BH, Hosseini MA, Zeraati H. Comparing serum basal and follicular fluid levels of anti-Mullerian hormone as a predictor of in vitro fertilization outcomes in patients with and without polycystic ovary syndrome. Ann Saudi Med 2010; 30: 442-447.
5. Seifer DB, MacLaughlin DT, Christian BP. Early follicular serum MIS levels are associated with ovarian response during ART cycles. Fertil Steril 2002; 77: 468-471.
6. Van Rooij IAJ, Broekmans FJM, te Velde ER, Fauser BCJM, Bancsi LFJMM, de Jong FH. Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002; 17: 3065-3071.
7. Velde ER, Pearson PL. The variability of female reproductive aging. Hum Reprod 2002; 8: 141-154.
8. Bukman A, Heineman MJ. Ovarian reserve testing and the use of prognostic models in patients with subfertility. Hum Reprod 2001; 7: 581-590.
9. VanRooij IA, Broekmans FJ, Scheffer GJ. Serum AMH levels best reflect there productive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005; 83: 979-987.
10. Fıçıcıoğlu C, Kutlu T, Bakacak Z. Early folliculer AMH hormone as an indicator of ovarian reserve. Fertil Steril 2006; 85: 592-596.
11. Hazout A, Bouchard P, Seifer DB. Serum MH appears to be a more discriminatory marker of assisted reproductive technology outcome than FSH, inhibin B, or estradiol. Fertil Steril 2004; 82: 1323-1329.
12. Lekamge DN, Barry M, Kolo M. AMH as a predictor for IVF outcome. Reprod Biomed Online 2007; 14: 602-610.
13. Smeenk JM, Sweep FC, Zielhuis GA. AMH predicts ovarian responsiveness, but not embryo quality or pregnancy, after IVF or ICSI. Fertil Steril 2007; 87: 223-226.
14. Eldar-Geva T, Ben-Chetrit A, Spitz IM. Dynamic assays of inhibin B, AMH and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 2005; 20: 3178-3183.
15. Silberstein T, MacLaughlin DT, Shai I. MIS levels at the time of HCG administration in IVF cycles predicts both ovarian reserve and embryo morphology. Hum Reprod 2006; 21: 159-163.
16. Takahashi C, Fujito A, Kazuka M. AMH substance from follicular fluid is positively associated with success in oocyte fertilization during IVF. Fertil Steril 2008; 89: 586-591.
17. Ebner T, Sommergruber M, Moser M. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 2006; 21: 2022-2026.
18. Setti AS, Figueira RCS, Braga DPAF, Colturato SS, Iaconelli Jr A, Borges Jr E. Relationship between oocyte abnormal morphology and intracytoplasmic sperm injection outcomes: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2011; 159: 364-370.
19. Figueira RD, de Almeida Ferreira Braga DP, Semiao-Francisco L, Madaschi C, Iaconelli Jr A, Borges Jr E. Metaphase II human oocyte morphology: contributing factors and effects on fertilization potential and embryo developmental ability in ICSI cycles. Fertil Steril 2010; 94: 1115-1117.
20. Boomsmaand CM, Macklon NS. What can the clinician do to improve implantation? Reprod Biomed Online 2006; 13: 845-855.